http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2010001236-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6042509de7544921c96de43b9da1438
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-14
filingDate 2008-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f5d4df4fba590e160e2bb249d6dcd79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d335a12c4548ab791dbfd717261eae5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74fbae08f41889249eb605731cd4bdb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56db7e66736f333b7f3914276fa959cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c41ab037c046aa0d85b3ec1677b1c77b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81e1d59d9c74eacc6fc328810f080a81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75777826be4bf9ab40aab1c282de4763
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae21bedda17939073b36e7e1f9928bc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4d0f1e16ad22b3c8c447591751116b7
publicationDate 2010-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2010001236-A
titleOfInvention DERIVATIVES OF 5-PHENYL-ISOXAZOL-3-CARBOXAMIDE AS MODULATORS OF THE TRANSITIONAL POTENTIAL RECEIVER V1 (TRPV1).
abstract The present invention relates to the isoxazol-3-carboxamide derivative having the general Formula (1), or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions thereof, as well as to the use of isoxazol-3-carboxamide derivatives for the treatment of TRPV1-mediated disorders such as acute and chronic pain disorders, acute and chronic neuropathic pain, acute and chronic inflammatory pain, respiratory diseases, and lower urinary tract disorders.
priorityDate 2007-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ704Y3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22263119
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ697L1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6R5A3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409779655
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID193034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO35433
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID445457
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100135466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421969768
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8NER1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6RX08
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID541773
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID83810

Total number of triples: 44.